KIORA PHARMACEUTICALS, INC. Capital Units, Value
KIORA PHARMACEUTICALS, INC. (KPRX) had Capital Units, Value of $3.40 million as of 2016-05-06, per its 10-Q filed 2017-08-04.
Discontinued › Notes › Equity
us-gaap:CapitalUnits · last filed 2017-08-04
- 2016-05-06: Capital Units, Value $3.40M.
| Period end | Capital Units, Value |
|---|---|
| 2016-05-06 | $3.40M 10-Q · filed 2017-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |